The 22nd“Takamatsu”International Symposium for PD & MD in TOKYO第22回高松国際パーキンソン病シンポジウムin Tokyo

Symposium 1　　Diagnosis and Management in Movement Disorders
Chair：Ryosuke Takahashi, Kenjiro Ono

• 1．Parkinson's disease
  Speaker：Eduardo Tolosa
• 2．Multiple System Atrophy - Clinical Challenges and Recent
  Advances Speaker：Werner Poewe
• 3．Common Pitfalls in Hyperkinetic Disorders: Case-Based Examples
  Speaker：Roongroj Bhidayasiri

Lunch on Seminar
Chair：Kazushi Takahashi

• 1．Therapy for early stage of Parkinson’s Disease
  Speaker：Eng-King Tan
• 2．Pitfalls on the diagnosis and management of cases with hyperkinetic disorders
  Speaker：Loius Tan

Symposium 2 Therapeutic Tagert in Movement Disorders
Chair：Atsushi Takeda

• 1．Blood biomarkers and Neurodegenerative disorders
  Speaker：Shinji Saiki
• 2．Where does Parkinson's disease begin?-Microbiota double hit hypothesis : gut-brain hypothesis in Parkinson's disease
  Speaker：Masaaki Hirayama

Premium Seminar：Eisai Co., Ltd.
Chair：Genko Oyama

• 1．Neuropathology of α-synucleinopathies
  Speaker：Masaki Takao
• 2．Recent experiences of deep brain stimulation for Parkinson’s disease
  Speaker：Hidemoto Saiki

Evening Seminar
Chair：Yoshikazu Ugawa

• 1．Brain Networks in Parkinson’s disease
  Speaker：Wataru Sako
• 2．What roles of cerebellum in PD?
  Speaker：Hirohisa Watanabe

Symposium 3
Chair：Yasushi Shimo

• 1．Amantadine for the treatment of Parkinson disease and other movement disorder
  Speaker：Olivier Rascol
• 2．Pathomechanisms of Parkinson's disease due to prosaposin gene mutations
  Speaker：Yutaka　Oji

Hot Topics
Chair：Tatsushi Toda, Yoshio Tsuboi

• 1．Molecular pathogenesis of Parkinson's disease illuminated by small fish models
  Speaker：Hideaki Matsui
• 2．Rehabilitation for Parkinson’s Disease
  Speaker：Tadashi Ichikawa
• 3．Exosomes contribute to the development of Parkinson’s disease
  Speaker：Taiji Tsunemi

Lunch on seminar
Chair：Masahiko Tomiyama

• 1．Genomic background of Parkinson's disease and clinical application of genomics towards the development of percision
  Speaker：Wataru Satake
• 2．Treatment of autonomic dysfunction in movement disorders
  Speaker：Tomohiko Nakamura

Symposium 4 How to establish the QOL of PD：Takeda Pharmaceutical Co., Ltd.
Chair： Yasuyuki Okuma, Kazuko Hasegawa

• 1．Neuropsychiatric complications in Parkinson’s disease
  Speaker：Jinsoo Koh
• 2．Restless Legs Syndrome in patients with Parkinson disease
  Speaker：Yuichi Inoue
• 3．Multidisciplinary Care for PD
  Speaker：Morinobu Seki

Educational Lecture：Sumitomo Pharma Co., Ltd.
Chair：Satoshi Orimo

• 1．α-synuclein; Biomarker of Synucleinopathy
  Speaker：Taku Hatano
• 2．How does alpha-synuclein transfer from cell to cell: A cell biological perspective
  Speaker：Takafumi Hasegawa

VTR Session
Chair：Mitsutoshi Yamamoto, Genjiro Hirose

Speaker：Nobutaka Hattori

認知機能障害を伴うレビー小体病のマネジメント：協和キリン株式会社
Chair：伊藤 和則　Speaker：平野 成樹

運動障害疾患と運動ニューロン病：エフピー株式会社
Chair：金井 数明　Speaker：狩野 修

運動障害疾患診療に役立つバイオマーカー：アッヴィ合同会社
Chair：柏原 健一　Speaker：上野 真一

運動障害疾患と加齢：小野薬品工業株式会社
Chair：花島 律子　Speaker：荒若 繁樹

PDのうつ update 2023：大塚製薬株式会社
Chair：前田 哲也　Speaker：永山 寛